Accepted for Publication: September 13, 2022.
Published: November 9, 2022. doi:10.1001/jamanetworkopen.2022.41144
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Khazanchi R et al. JAMA Network Open.
Corresponding Author: Rohan Khazanchi, MD, MPH, Brigham & Women’s Hospital, 75 Francis St, Boston, MA 02115 (firstname.lastname@example.org).
Author Contributions: Dr Khazanchi and Mr Strumpf had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Khazanchi, Strumpf, Powers, McManus.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Khazanchi, Essien.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Khazanchi, Strumpf, Powers.
Obtained funding: McManus.
Administrative, technical, or material support: Strumpf, Powers, McManus.
Conflict of Interest Disclosures: Dr Khazanchi reported receiving personal fees from the New York City Department of Health and Mental Hygiene and grants from the Infectious Diseases Society of America Foundation outside the submitted work. Dr Essien reported receiving grants from the Department of Veterans Affairs outside the submitted work. Mr Powers reported receiving grants from the University of Virginia Global Infectious Diseases Institute during the conduct of the study. Dr McManus reported receiving grants from and owning stock in Gilead Sciences Inc outside the submitted work. No other disclosures were reported.
Funding/Support: This work was supported by the University of Virginia Global Infectious Diseases Institute.
Role of the Funder/Sponsor: The University of Virginia Global Infectious Diseases Institute had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Information: The statistical code is available on request from Mr Strumpf (email@example.com). Data sets are publicly available from sources noted in Methods.
JAW , Kelleher
J , Magid
et al. Dispensing of oral antiviral drugs for treatment of COVID-19 by zip code–level social vulnerability—United States, December 23, 2021-May 21, 2022. MMWR Morb Mortal Wkly Rep
. 2022;71(25):825-829. doi:10.15585/mmwr.mm7125e1
JL , Feehan
AK , Molinari
et al. Racial and ethnic disparities in receipt of medications for treatment of COVID-19—United States, March 2020-August 2021. MMWR Morb Mortal Wkly Rep
. 2022;71(3):96-102. doi:10.15585/mmwr.mm7103e1
JC , Hirsch
EB , Ko
et al. A call to action: a need for initiatives that increase equitable access to COVID-19 therapeutics. Lancet Reg Health Am
. 2022;11:100263. doi:10.1016/j.lana.2022.100263PubMedCrossref